646 related articles for article (PubMed ID: 28024890)
41. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.
Cuiné JF; Charman WN; Pouton CW; Edwards GA; Porter CJ
Pharm Res; 2007 Apr; 24(4):748-57. PubMed ID: 17372700
[TBL] [Abstract][Full Text] [Related]
42. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
43. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
Müllertz A; Ogbonna A; Ren S; Rades T
J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
[TBL] [Abstract][Full Text] [Related]
44. Development of lipid-based SEDDS using digestion products of long-chain triglyceride for high drug solubility: Formulation and dispersion testing.
Desai HH; T M Serajuddin A
Int J Pharm; 2024 Apr; 654():123953. PubMed ID: 38417725
[TBL] [Abstract][Full Text] [Related]
45. Drug solubility in fatty acids as a formulation design approach for lipid-based formulations: a technical note.
Lee YC; Dalton C; Regler B; Harris D
Drug Dev Ind Pharm; 2018 Sep; 44(9):1551-1556. PubMed ID: 29873584
[TBL] [Abstract][Full Text] [Related]
46. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
[TBL] [Abstract][Full Text] [Related]
47. Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system.
Lee DR; Ho MJ; Jung HJ; Cho HR; Park JS; Yoon SH; Choi YS; Choi YW; Oh CH; Kang MJ
Int J Nanomedicine; 2016; 11():1109-17. PubMed ID: 27051286
[TBL] [Abstract][Full Text] [Related]
48. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
Gursoy RN; Benita S
Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
[TBL] [Abstract][Full Text] [Related]
49. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
50. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
[TBL] [Abstract][Full Text] [Related]
51. Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate.
Bajaj A; Rao MR; Khole I; Munjapara G
Drug Dev Ind Pharm; 2013 May; 39(5):635-45. PubMed ID: 22564007
[TBL] [Abstract][Full Text] [Related]
52. Impact of Lipid-Based Drug Delivery Systems on the Transport and Uptake of Insulin Across Caco-2 Cell Monolayers.
Li P; Nielsen HM; Müllertz A
J Pharm Sci; 2016 Sep; 105(9):2743-2751. PubMed ID: 26921121
[TBL] [Abstract][Full Text] [Related]
53. Lipids and Surfactants: The Inside Story of Lipid-Based Drug Delivery Systems.
Pandey V; Kohli S
Crit Rev Ther Drug Carrier Syst; 2018; 35(2):99-155. PubMed ID: 29717664
[TBL] [Abstract][Full Text] [Related]
54. Pharmaceutical optimization of lipid-based dosage forms for the improvement of taste-masking, chemical stability and solubilizing capacity of phenobarbital.
Monteagudo E; Langenheim M; Salerno C; Buontempo F; Bregni C; Carlucci A
Drug Dev Ind Pharm; 2014 Jun; 40(6):783-92. PubMed ID: 23607724
[TBL] [Abstract][Full Text] [Related]
55. Development of solid SEDDS, VI: Effect of precoating of Neusilin
Gumaste SG; Freire BOS; Serajuddin ATM
Eur J Pharm Sci; 2017 Dec; 110():124-133. PubMed ID: 28212981
[TBL] [Abstract][Full Text] [Related]
56. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture.
Joshi HN; Tejwani RW; Davidovich M; Sahasrabudhe VP; Jemal M; Bathala MS; Varia SA; Serajuddin AT
Int J Pharm; 2004 Jan; 269(1):251-8. PubMed ID: 14698596
[TBL] [Abstract][Full Text] [Related]
57. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
[TBL] [Abstract][Full Text] [Related]
58. Development and Characterization of Solid Self-emulsifying Drug Delivery System of Cilnidipine.
Bakhle SS; Avari JG
Chem Pharm Bull (Tokyo); 2015; 63(6):408-17. PubMed ID: 26027464
[TBL] [Abstract][Full Text] [Related]
59. Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
Takahashi Y; Kondo H; Yasuda T; Watanabe T; Kobayashi S; Yokohama S
Int J Pharm; 2002 Oct; 246(1-2):85-94. PubMed ID: 12270611
[TBL] [Abstract][Full Text] [Related]
60. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier.
Van Speybroeck M; Williams HD; Nguyen TH; Anby MU; Porter CJ; Augustijns P
Mol Pharm; 2012 Sep; 9(9):2750-60. PubMed ID: 22870936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
